Fundz

Advanced NanoTherapies

Los Gatos, California, United States · Biotechnology, Health Care, Manufacturing

AdvNanoT is based on biodegradable nanoparticles (NP) specifically designed to have higher vascular uptake and cellular retention. We are developing novel Sirolimus-based medical devices to treat atherosclerosis and blockage for Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD).

Key facts

Headquarters
Los Gatos, California, United States
Employees
17
Industries
Biotechnology, Health Care, Manufacturing
Status
Private
Website
http://advancednanotherapies.com
LinkedIn
Company page

Recent activity at Advanced NanoTherapies

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

Advanced NanoTherapies funding history

DateRoundAmount
Jun 2026Series B$31.0M
Aug 2023Seed$4.0M
Jun 2022Series A$7.2M
Jan 2022Venture$9.2M
Dec 2019Seed$640K

Leadership

  • Regina Groves, Director
  • Jerett Creed, Director
  • Mehdi Shishehbor, Director
  • Phillippe Urbain, Director
  • Marwan Berrada-Sounni, Executive Officer, Director
  • Michael Mandel, Head of Corporate Development

Verified email and direct lines for Advanced NanoTherapies’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.

Companies similar to Advanced NanoTherapies

About Advanced NanoTherapies: questions and answers

What does Advanced NanoTherapies do?

AdvNanoT is based on biodegradable nanoparticles (NP) specifically designed to have higher vascular uptake and cellular retention. We are developing novel Sirolimus-based medical devices to treat atherosclerosis and blockage for Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD).

Where is Advanced NanoTherapies headquartered?

Advanced NanoTherapies is headquartered in Los Gatos, California, United States.

How many employees does Advanced NanoTherapies have?

Advanced NanoTherapies has about 17 employees.

Has Advanced NanoTherapies raised funding?

Yes. Fundz has recorded 5 funding events for Advanced NanoTherapies. The most recent, Series B of $31.0M, was in Jun 2026.

What is the latest news on Advanced NanoTherapies?

On Jun 2, 2026, Advanced NanoTherapies raised over $31M in Series B funding led by S3 Ventures to scale manufacturing and advance clinical trials.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Advanced NanoTherapies across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.